BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19210573)

  • 1. Prion Mutations in Republic of Republic of Korea, China, and Japan.
    Kim DY; Shim KH; Bagyinszky E; An SSA
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Genetic Creutzfeldt-Jakob Disease With a G114V Mutation and One Octapeptide Repeat Deletion as a Mimic of Frontotemporal Dementia.
    Lin X; Xu Y; Zhen Z; Xiao K; Chen X; Yang J; Guan H; Shi Q; Dong X; Wang J; Guo Y
    Front Neurol; 2022; 13():888309. PubMed ID: 35812092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cellular Prion Protein and the Hallmarks of Cancer.
    Mouillet-Richard S; Ghazi A; Laurent-Puig P
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cellular Prion Protein in Cancer Biology: A Potential Therapeutic Target.
    Ding M; Chen Y; Lang Y; Cui L
    Front Oncol; 2021; 11():742949. PubMed ID: 34595121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.
    Guo T; Ma H; Zhou Y
    PeerJ; 2019; 7():e7313. PubMed ID: 31333911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular prion protein contributes to LS 174T colon cancer cell carcinogenesis by increasing invasiveness and resistance against doxorubicin-induced apoptosis.
    Chieng CK; Say YH
    Tumour Biol; 2015 Sep; 36(10):8107-20. PubMed ID: 25983001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.
    Zhou L; Shang Y; Liu C; Li J; Hu H; Liang C; Han Y; Zhang W; Liang J; Wu K
    Int J Cancer; 2014 Nov; 135(10):2329-37. PubMed ID: 24706505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance.
    Wang JH; Du JP; Zhang YH; Zhao XJ; Fan RY; Wang ZH; Wu ZT; Han Y
    World J Gastroenterol; 2011 Sep; 17(35):3986-93. PubMed ID: 22046086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cellular Prion Protein: A Promising Therapeutic Target for Cancer.
    Go G; Lee SH
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Multifaceted Functions of Prion Protein (PrP
    Abi Nahed R; Safwan-Zaiter H; Gemy K; Lyko C; Boudaud M; Desseux M; Marquette C; Barjat T; Alfaidy N; Benharouga M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of PrPC (1-OPRD) in biological activities of gastric cancer cell lines.
    Liang J; Wang J; Luo G; Pan Y; Wang X; Guo C; Zhang D; Yin F; Zhang X; Liu J; Wang J; Guo X; Wu K; Fan D
    J Cell Mol Med; 2009; 13(11-12):4453-64. PubMed ID: 19210573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS.
    Liang J; Pan Y; Zhang D; Guo C; Shi Y; Wang J; Chen Y; Wang X; Liu J; Guo X; Chen Z; Qiao T; Fan D
    FASEB J; 2007 Jul; 21(9):2247-56. PubMed ID: 17409275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency occurrence of 1-OPRD variant of PRNP gene in gastric cancer cell lines and Chinese population with gastric cancer.
    Liang J; Wang JB; Pan YL; Wang J; Liu LL; Guo XY; Sun L; Lin T; Han S; Xie HH; Yin F; Guo XG; Fan D
    Cell Biol Int; 2006 Nov; 30(11):920-3. PubMed ID: 16914329
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.